vcfirmsdirectory.com

Venture capital · Early to growth stage · Est. 1972

Sofinnova Partners

Paris-based life sciences venture firm that runs several dedicated strategies investing from seed to later stage in healthcare and sustainability, with offices in Paris, Milan and London.

Paris · Milan · LondonRegistered · Paris
New investments · 12 months
Fund vehiclesPublic
18
18 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 25 Oct 2026, 02:04 CETSources: sofinnovapartners.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round Sofinnova Partners joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is Sofinnova Partners right for your round?

Is Sofinnova Partners a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
18
18 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

SOFINNOVA CROSSOVER IUS private fund · Active · France · $609.9M gross assets · filed 27 Mar 2026
SOFINNOVA CAPITAL IXUS private fund · Active · France · $255.3M gross assets · filed 27 Mar 2026
SOFINNOVA CAPITAL VIIIUS private fund · Active · France · $246.3M gross assets · filed 27 Mar 2026
SOFINNOVA CAPITAL XUS private fund · Active · France · $207.1M gross assets · filed 27 Mar 2026
SOFINNOVA MD START IIIUS private fund · Active · France · $101.2M gross assets · filed 27 Mar 2026
SOFINNOVA DIGITAL MEDICINE IUS private fund · Active · France · $91.6M gross assets · filed 27 Mar 2026
SOFINNOVA INDUSTRIAL BIOTECH IIUS private fund · Active · France · $90.2M gross assets · filed 27 Mar 2026
SOFINNOVA INDUSTRIAL BIOTECH IUS private fund · Active · France · $73.5M gross assets · filed 27 Mar 2026
SOFINNOVA TELETHON SCA RAIFUS private fund · Active · Luxembourg · $62.8M gross assets · filed 27 Mar 2026
SOFINNOVA CAPITAL VIIUS private fund · Active · France · $24.1M gross assets · filed 27 Mar 2026
SOFINNOVA GREEN SEED FUNDUS private fund · Active · France · $24M gross assets · filed 27 Mar 2026
SOFINNOVA CAPITAL VIUS private fund · Active · France · $22.5M gross assets · filed 27 Mar 2026
6 more fund vehiclesSEC adviser filings
Deployed (new cheques)
Next fund expected

Latest investments

BetaRounds Sofinnova Partners joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

7 rounds in the last 12 months

Round sizes, Sofinnova Partners’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

AAVantgarde BioABIONYX PharmaAbivaxAblynx NVActitheraAddex TherapeuticsAdvanced Perfusion DiagnosticsAfyrenAlia TherapeuticsAmolyt Pharmaand 134 more

Portfolio and exits

Every company Sofinnova Partners backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where Sofinnova Partners puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet Sofinnova Partners

Events where Sofinnova Partners’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet Sofinnova Partners’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

22 Sep 2026New deal
22 Jun 2026New deal
3 Jun 2026New deal
27 May 2026New deal
6 May 2026New deal
27 Mar 2026Fund filingForm ADV filed by SOFINNOVA PARTNERS: 18 private funds, $1.9B in gross assets.SEC Form ADV · public record
11 Dec 2025New deal
3 Dec 2025New deal

Founders also look at

Frequently asked questions

Sofinnova Partners is based in Paris, France. It also has offices in Milan and London.

In 1972.

18 fund vehicles are on public registers (SEC adviser filings), including SOFINNOVA CROSSOVER I, SOFINNOVA CAPITAL IX and SOFINNOVA CAPITAL VIII.

Stages: Seed, Late stage. Sectors: Biotech, Medtech, Health tech, Life sciences, Food and agtech. From the firm’s own website.

Backs scientist-led companies that bring new products to patients or solve environmental problems, in biopharma, medtech, digital medicine and industrial biotech. It often founds or leads rounds, builds companies hands-on, and believes patient impact translates into financial returns. From the firm’s own website.

Sofinnova Partners lists 144 portfolio companies on its website, including AAVantgarde Bio, ABIONYX Pharma, Abivax, Ablynx NV and Actithera.

Firms whose websites list some of the same companies include Atlas Venture, SV Health Investors and 415 Capital.

Know before Sofinnova Partners’s next round is announced.

PRO tracks Sofinnova Partners’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

Sofinnova PartnersGet Sofinnova Partners’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.